Cinedigm Digital Cinema Corp (CIDM) Jumps 11.07% on January 04

Equities Staff |

Cinedigm Digital Cinema Corp (CIDM) was among the biggest gainers on the Russell 2000 for Monday January 04 as the stock popped 11.07% to $0.29, representing a gain of $0.0289 per share. Some 498,678 shares traded hands on 333 trades, compared with an average daily volume of 254,259 shares out of a total float of 75.09 million. The stock opened at $0.27 and traded with an intraday range of $0.35 to $0.27.

After today's gains, Cinedigm Digital Cinema Corp reached a market cap of $21.77 million. Cinedigm Digital Cinema Corp has had a trading range between $1.79 and $0.24 over the last year, and it had a 50-day SMA of $0.41 and a 200-day SMA of $0.72.

Cinedigm Corp is a distributor of movie & television & servicer of digital cinema assets in both North America & other international countries. Its four segments are Phase I Deployment, Phase II Deployment, Services, & Content & Entertainment.

Cinedigm Digital Cinema Corp is based out of New York, NY and has some 141 employees. Its CEO is Christopher J. McGurk.

For a complete fundamental analysis analysis of Cinedigm Digital Cinema Corp, check out’s Stock Valuation Analysis report for CIDM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…